1. The reduction of experimentally induced inflammation by sulfhydryl compounds;Bailey, K.R.; Sheffner, A.L.;Biochemical Pharmacology,1976
2. Acetylcysteine in the treatment of rheumatoid arthritis. Unpublished study Courtesy of Mead-Johnson Research Center;Barley, J.P.; Vanal, M.E.,1970
3. N-acetylcysteine inactivates migration inhibition factor and delayed hypersensitivity reactions;Bartfeld, H.; Ataynata, T.;Nature New Biology,1971
4. Failure of dimethyle sulfoxide in the treatment of scleroderma;Binnick, S.A.; Shore, S.S.; Corman, A.; Fleischmeyer, R.;Archives of Dermatology,1977
5. Muscle disease in progressive systemic sclerosis;Clements, P.J.; Furst, D.E.Campion; S., D.; Bohan, A.; Harris, R.; Levy, J.; Paulus, H.E.;Arthritis and Rheumatism,1978